title: Antisickling activity of sodium cromoglicate in sickle-cell disease.
abstract: Two groups of patients with sickle-cell disease were given a single dose of sodium cromoglicate by inhalation or nasal route. The striking decrease in sickle cells after treatment by both routes lends support to the role of sodium cromoglicate in sickle-cell disease treatment.
authors.forename: M
authors.initials: M
authors.lastname: Toppet
authors.forename: A B
authors.initials: AB
authors.lastname: Fall
authors.forename: A
authors.initials: A
authors.lastname: Ferster
authors.forename: P
authors.initials: P
authors.lastname: Fondu
authors.forename: C
authors.initials: C
authors.lastname: Mélot
authors.forename: R
authors.initials: R
authors.lastname: Vanhaelen-Fastré
authors.forename: M
authors.initials: M
authors.lastname: Vanhaelen
mesh_terms: D000280:Administration, Inhalation; D000281:Administration, Intranasal; D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000986:Antisickling Agents / Q000494:pharmacology*; D002648:Child; D004205:Cromolyn Sodium / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans
chemical_list: D000986:Antisickling Agents; D004205:Cromolyn Sodium